PGNX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Progenics Pharmaceuticals, Inc.'s money market investment for the quarter that ended in Dec. 2013 was $-65.86 Mil. It means Progenics Pharmaceuticals, Inc. paid $65.86 Mil to invest on the money market.
Compared with last quarter ($-75.60 Mil in Sep. 2013 ), Progenics Pharmaceuticals, Inc. paid less money to invest on the money market in Dec. 2013 ($-65.86 Mil).
Money Market Investments carried on banks' balance sheet.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Progenics Pharmaceuticals, Inc. Annual Data
Progenics Pharmaceuticals, Inc. Quarterly Data